KVUE • NYSE
Kenvue Inc.
$16.46
Stock Details
| Market Cap | 31,545,180,344 |
|---|---|
| Day Change | 0.23 (1.42%) |
| Volume | 63,882,025 |
| Avg Volume | 34,967,922 |
| Price Range | 14.02-25.17 |
Overview
| Country | US |
|---|---|
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Exchange | NYSE |
Company Profile
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
Financial Overview
| 52 Week High | 25.17 |
|---|---|
| 52 Week High Date | 2025-05-08 |
| 52 Week Low | 14.02 |
| 52 Week Low Date | 2025-10-30 |
| 10D Avg Trading Vol | 54.5303 |
| YTD Price Return Daily | -25.1991 |
| MTD Price Return Daily | 11.1343 |
Cash Flow
| TTM/Share | |
|---|---|
| Annual/Share | 0.6976 |
| Quarterly/Share | 0.851 |
Price-to-Earnings
| Annual Ratio | 0.9627 |
|---|---|
| Quarterly Ratio | 0.9776 |
| TTM | 22.2384 |
Revenue
| 3Y Growth | 0.88 |
|---|---|
| 5Y Growth | 1.53 |
| Annual/Share | -4.03 |
| TTM/Share | 7.8532 |
| 5Y Share Growth | 1.17 |
Earnings Per Share
| Annual | 0.5356 |
|---|---|
| 3Y Growth | -20.73 |
| 5Y Growth | -6.75 |
| Quarterly YOY Growth | 621.19 |
Price-to-Book
| Ratio | 2.9389 |
|---|---|
| Annual Ratio | 4.2002 |
| TTM | 3.745 |